1. Journal Papers

This table browses all dspace content
Issue DateTitleJournal Title
2022Longitudinal quantitative assessment of coronary atherosclerosis related to normal systolic blood pressure maintenance in the absence of established cardiovascular disease CLINICAL CARDIOLOGY
2022Liver-directed concurrent chemoradiotherapy versus sorafenib in hepatocellular carcinoma with portal vein tumor thrombusJOURNAL OF CLINICAL ONCOLOGY
2022Lifestyle Modification in the Management of Metabolic Syndrome: Statement From Korean Society of CardioMetabolic Syndrome (KSCMS) KOREAN CIRCULATION JOURNAL
2022Isatuximab plus carfilzomib and dexamethasone in East Asian patients with relapsed multiple myeloma: IKEMA subgroup analysisINTERNATIONAL JOURNAL OF HEMATOLOGY
2022Isatuximab in Combination with Lenalidomide and Dexamethasone in Patients with High-Risk Smoldering Multiple Myeloma: Updated Safety Run-in Results from the Randomized Phase 3 Ithaca StudyBLOOD
2022Interim Results of the Phase 1 Study of Tnb-486, a Novel CD19xCD3 T-Cell Engager, in Patients with Relapsed/Refractory (R/R) B-NHLBLOOD
2022In-Silico Analysis of Phytocompounds of Olea europaea as Potential Anti-Cancer Agents to Target PKM2 Protein MOLECULES
2022Incidence and Survival Rates of Cutaneous Melanoma in South Korea Using Nationwide Health Insurance Claims Data CANCER RESEARCH AND TREATMENT
2022Implications of a blood sample with an extremely high lipid content in the emergency department: a case reportSIGNA VITAE
2022Impact of mutation status on efficacy outcomes in TOPAZ-1: A phase III study of durvalumab (D) or placebo (PBO) plus gemcitabine and cisplatin ( plus GC) in advanced biliary tract cancer (BTC)ANNALS OF ONCOLOGY
2022Impact of expanding hepatitis B treatment guidelines: A modelling and economic impact analysisALIMENTARY PHARMACOLOGY & THERAPEUTICS
2022Impact of BCL2/MYC Protein Dual Expression and Other Clinical Factors on the Risk of Central Nervous System Progression in Patients with Primary Breast Diffuse Large B-Cell LymphomaBLOOD
2022Iatrogenic aortic dissection during right transradial intervention in a patient with aberrant right subclavian artery: A case report WORLD JOURNAL OF CLINICAL CASES
2022Giredestrant (GDC-9545) vs physician choice of endocrine monotherapy (PCET) in patients (pts) with ER+, HER2-locally advanced/metastatic breast cancer (LA/mBC): Primary analysis of the phase II, randomised, open-label acelERA BC studyANNALS OF ONCOLOGY
2022Genomic profiling as a response predictor of second-line treatment in advanced gastric cancer patients: Post-hoc analyses of two phase Ib/II trialsJOURNAL OF CLINICAL ONCOLOGY
2022Genomic analysis of plasma cell-free DNA in patients with heavily pretreated HER-2+metastatic breast cancer (MBC)ANNALS OF ONCOLOGY
2022Four Times of Relapse of Plasmodium vivax Malaria Despite Primaquine Treatment in a Patient with Impaired Cytochrome P450 2D6 Function KOREAN JOURNAL OF PARASITOLOGY
2022First-line pembrolizumab plus chemotherapy versus chemotherapy in advanced esophageal cancer: Longer-term efficacy, safety, and quality-oflife results from the phase 3 KEYNOTE-590 studyJOURNAL OF CLINICAL ONCOLOGY
2022First-line pembrolizumab (pembro) with or without lenvatinib (lenva) in patients with advanced urothelial carcinoma (LEAP-011): A phase 3, randomized, double-blind study.JOURNAL OF CLINICAL ONCOLOGY
2022EXPLORE-LC: A multi-site real-world evidence research platform for non-small cell lung cancer in Asia-PacificANNALS OF ONCOLOGY

Recent Submissions

Browse

Links